TY  - RPRT
TI  - miR-425 suppresses EMT and inhibits the development of TNBC (triple-negative breast cancer) by targeting TGF-β 1/SMAD 3 signaling pathway
AU  - Liu, Y.
AU  - Qiao, H.
AU  - chen, j.
PY  - 2018
DO  - 10.1101/477877
UR  - https://www.biorxiv.org/content/10.1101/477877v1
ID  - 10.1101/477877
ER  -